Quthero is a private company advancing regenerative therapies based on its proprietary Q-peptide technology for applications in dermatology and cardiology. Q-peptide is a synthetic, bioactive, peptide sequence derived from Angiopoietin-1, with documented regenerative and anti-inflammatory properties.

Q-peptide platform enables versatile applications in areas where cell survival, anti-inflammatory effects, and regenerative support are critical. Quthero’s pipeline focuses on applications of post-aesthetic procedures, wound healing and regeneration, and cardiovascular health.